Richard Burr said...

Without Orrin, we wouldn't have a generic drug industry.

It is time that we hold the FDA accountable.

I question whether the agreements both passed and proposed reflect a good deal for patients they are designed to serve.

More than 278 therapies have been approved under the accelerated approval pathway over the 30 year history, saving and i...